Skip to main content

Table 3 Proportion of days using sedative agents

From: International Analgesia, Sedation, and Delirium Practices: a prospective cohort study

Benzodiazepines
 Overall 17,627/24925 (71%) 12,955/23520 (55%) − 0.156 (− 0.16 to − 0.152) < 0.001
 Europe 7178/11773 (61%) 4939/10468 (47%) − 0.138 (− 0.145 to − 0.131) < 0.001
 US/Canada 1803/2439 (74%) 372/1030 (36%) − 0.378 (− 0.397 to − 0.359) < 0.001
 Asia 2725/3401 (80%) 2093/4507 (46%) − 0.337 (− 0.346 to − 0.328) < 0.001
 Africa 267/281 (95%) 448/500 (90%) − 0.054 (− 0.069 to − 0.039) < 0.001
 Australia/New Zealand 887/2016 (44%) 122/577 (21%) − 0.229 (− 0.255 to − 0.203) < 0.001
 Latin America 4767/5015 (95%) 4981/6438 (77%) − 0.177 (− 0.183 to − 0.171) < 0.001
Propofol
 Overall 9526/24925 (38%) 9728/23520 (41%) 0.031 (0.027 to 0.035) < 0.001
 Europe 6012/11773 (51%) 6095/10468 (58%) 0.072 (0.064 to 0.08) < 0.001
 US/Canada 829/2439 (34%) 672/1030 (65%) 0.313 (0.294 to 0.332) < 0.001
 Asia 876/3401 (26%) 1380/4507 (31%) 0.049 (0.039 to 0.059) < 0.001
 Africa 15/281 (5%) 34/500 (7%) 0.015 (0.002 to 0.028) 0.023
 Australia/New Zealand 1545/2016 (77%) 496/577 (86%) 0.093 (0.069 to 0.117) < 0.001
 Latin America 249/5015 (5%) 1051/6438 (16%) 0.114 (0.108 to 0.12) < 0.001
Dexmedetomidine
 Overall 196/24925 (0.8%) 2615/23520 (11%) 0.103 (0.101 to 0.105) < 0.001
 Europe 24/11773 (0.2%) 609/10468 (6%) 0.056 (0.053 to 0.059) < 0.001
 US/Canada 5/2439 (0.2%) 84/1030 (8%) 0.08 (0.068 to 0.092) < 0.001
 Asia 14/3401 (0.4%) 1309/4507 (29%) 0.286 (0.28 to 0.292) < 0.001
 Africa 0/281 (0%) 0/500 (0%)
 Australia/New Zealand 32/2016 (1.6%) 59/577 (10%) 0.086 (0.07 to 0.102) < 0.001
 Latin America 121/5015 (2.4%) 554/6438 (9%) 0.062 (0.057 to 0.067) < 0.001
  1. Proportion of days using each sedative out of the total days when any sedation was received